Your browser doesn't support javascript.
loading
The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
White, C Roger; Datta, Geeta; Wilson, Landon; Palgunachari, Mayakonda N; Anantharamaiah, G M.
Affiliation
  • White CR; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Datta G; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Wilson L; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Palgunachari MN; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Anantharamaiah GM; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, United States; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35294, United States. Electronic address: Ananth@uab.edu.
Chem Phys Lipids ; 219: 28-35, 2019 03.
Article in En | MEDLINE | ID: mdl-30707910
ABSTRACT
High density lipoprotein (HDL) is prone to modification by the oxidizing and chlorinating agent hypochlorite anion (OCl-). Oxidation of apolipoprotein (apo) A-I, the major protein in HDL, reduces ABCA-1 mediated cholesterol efflux and other protective responses to HDL. The apoA-I mimetic peptide 4F has been shown to undergo oxidation; however, the ability of the peptide to mediate cholesterol efflux remains intact. Here, we show that 4F protects apoA-I from hypochlorite-mediated oxidation. Mass spectral analysis of apoA-I shows that tyrosine residues that are prone to hypochlorite-mediated chlorination are protected in the presence of 4F. Furthermore, 4F enhances the cholesterol efflux ability of apoA-I to a greater extent than either 4F or apoA-I alone, even after hypochlorite oxidation. These observations suggest that apoA-I in lipid complexes may be protected by the presence of 4F, resulting in the preservation of its anti-inflammatory and anti-atherogenic properties. These studies also form the basis for the future studies of nanoparticles possessing both apoA-I and 4F.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Apolipoprotein A-I Limits: Humans Language: En Journal: Chem Phys Lipids Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Apolipoprotein A-I Limits: Humans Language: En Journal: Chem Phys Lipids Year: 2019 Document type: Article Affiliation country:
...